We are delighted to announce the appointment of Stephen Over as the Company's Chief Financial Officer and new member of the Executive team.
Stephen brings a wealth of senior leadership and strategic financing expertise with over 10 years of experience in the pharmaceuticals, biotech and medical devices industries.
The NeoPhore team attended the American Association for Cancer Research Annual Meeting in San Diego, 5 - 10 April 2024. In collaboration with The…
NeoPhore raises an additional £9.6m (USD $12.2m) Series B financing extension to further progress drug discovery pipeline • Italian investors, NE…
On Saturday October 14th, at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference in Boston, USA NeoPhore presented a first…